1. Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma‐derived factor concentrates. Issue 5 (9th May 2013) Authors: Soucie, J. Michael; Monahan, Paul E.; Kulkarni, Roshni; De Staercke, Christine; Recht, Michael; Chitlur, Meera B.; Gruppo, Ralph; Hooper, W. Craig; Kessler, Craig; Manco‐Johnson, Marilyn J.; Powell, Jerry; Pyle, Meredith; Riske, Brenda; Sabio, Hernan; Trimble, Sean Journal: Transfusion Issue: Volume 53:Issue 5(2013) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma‐derived factor concentrates in the era of nucleic acid test screening. Issue 6 (24th September 2012) Authors: Soucie, J. Michael; De Staercke, Christine; Monahan, Paul E.; Recht, Michael; Chitlur, Meera B.; Gruppo, Ralph; Hooper, W. Craig; Kessler, Craig; Kulkarni, Roshni; Manco‐Johnson, Marilyn J.; Powell, Jerry; Pyle, Meredith; Riske, Brenda; Sabio, Hernan; Trimble, Sean Journal: Transfusion Issue: Volume 53:Issue 6(2013) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. (11th September 2014) Authors: Powell, Jerry; Shapiro, Amy; Ragni, Margaret; Negrier, Claude; Windyga, Jerzy; Ozelo, Margareth; Pasi, John; Baker, Ross; Potts, James; Li, Shuanglian; Mei, Baisong; Pierce, Glenn F.; Robinson, Brian Journal: British journal of haematology Issue: Volume 168:Number 1(2015:Jan.) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗